US 11938124
Combination therapy for treatment of cancer
granted A61KA61K31/404A61K31/4045
Quick answer
US patent 11938124 (Combination therapy for treatment of cancer) held by PMV PHARMACEUTICALS, INC. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PMV PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/404, A61K31/4045, A61K31/438, A61K31/4439